Gary G Kushner Md Pa Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 16800 Nw 2nd Ave, Suite #102, North Miami Beach, FL 33169 Phone: 305-651-3057 Fax: 305-651-1807 |
Tamara Dresler P.a Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1380 Ne Miami Gardens Dr Ste 206, North Miami Beach, FL 33179 Phone: 786-461-4951 |
Thrive Behavioral Therapy Llc Behavioral Analyst Medicare: Not Enrolled in Medicare Practice Location: 17900 Ne 6th Ct, North Miami Beach, FL 33162 Phone: 717-758-4319 |
The Physicians Recovery Group Ll Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 1926 Ne 154th St, North Miami Beach, FL 33162 Phone: 305-949-2924 Fax: 305-949-9038 |
Kgh Therapy Counselor Medicare: Not Enrolled in Medicare Practice Location: 2031 Ne 196th Ter, North Miami Beach, FL 33179 Phone: 516-524-5660 |
Pcfy Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 17027 W Dixie Hwy, Suite 125, North Miami Beach, FL 33160 Phone: 786-449-8428 |
Jk Mental Health Inc Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1380 Ne Miami Gardens Dr Ste 205b, North Miami Beach, FL 33179 Phone: 786-277-9936 |
News Archive
Lupus is a rare but serious disease that mainly affects women of child-bearing age and occurs when the body's immune system goes awry, damaging a variety of organs.
You study the menu at a restaurant and decide to order the steak rather than the salmon. But when the waiter tells you about the lobster special, you decide lobster trumps steak. Without reconsidering the salmon, you place your order - all because of a trait called "transitivity."
Dr. Jacqueline Chu considered the man with a negative coronavirus test on the other end of the phone, and knew, her heart dropping, that the test result was not enough to clear him for work.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a therapy that would improve median overall survival over IFL (bolus 5-fluorouracil, generics/leucovorin, generics/irinotecan*) plus bevacizumab (Roche/Genentech/Chugai's Avastin), would earn a 60 percent patient share in stage IV colorectal cancer, according to surveyed U.S. oncologists. In Europe, such an agent would earn a 50 percent patient share, according to surveyed European oncologists.
› Verified 3 days ago